Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man.
The mechanism of somatostatin venoconstriction and tachyphylaxis in the human hand vein in vivo has been investigated. No cross-tachyphylaxis was observed between somatostatin and 5-hydroxytryptamine, noradrenaline, adrenaline, dopamine or tyramine-induced venoconstriction. Somatostatin potentiates the venoconstrictive activity of noradrenaline, adrenaline and dopamine, but not that of 5-hydroxytryptamine and tyramine. Phentolamine antagonizes the somatostatin-induced venoconstriction, whereas methysergide, haloperidol and morphine do not. It is suggested that somatostatin could act on specific receptors in the hand vein, but the mechanism of somatostatin venoconstriction and interaction with vasoactive monoamines remains to be defined.
D000328:Adult; D001679:Biogenic Amines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013004:Somatostatin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013618:Tachyphylaxis; D014439:Tyramine / Q000494:pharmacology; D014662:Vasoconstrictor Agents; D014680:Veins / Q000187:drug effects
D001679:Biogenic Amines; D014662:Vasoconstrictor Agents; D012701:Serotonin; D013004:Somatostatin; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine